These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 19765732)
1. Malignant intraductal papillary mucinous neoplasm: are we doing the right thing? Simons JP; Ng SC; Shah SA; McDade TP; Whalen GF; Tseng JF J Surg Res; 2011 May; 167(2):251-7. PubMed ID: 19765732 [TBL] [Abstract][Full Text] [Related]
2. Invasive IPMN and MCN: same organ, different outcomes? Kargozaran H; Vu V; Ray P; Bagaria S; Steen S; Ye X; Gagandeep S Ann Surg Oncol; 2011 Feb; 18(2):345-51. PubMed ID: 20809175 [TBL] [Abstract][Full Text] [Related]
3. Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy. Fan F; Lai EC; Xie F; Yang JM; Xu F; Kan T; Shen RX; Yang XY; Lau Wan Y; Wu MC Hepatogastroenterology; 2010; 57(99-100):635-9. PubMed ID: 20698241 [TBL] [Abstract][Full Text] [Related]
4. Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas. Riall TS; Stager VM; Nealon WH; Townsend CM; Kuo YF; Goodwin JS; Freeman JL J Am Coll Surg; 2007 May; 204(5):803-13; discussion 813-4. PubMed ID: 17481488 [TBL] [Abstract][Full Text] [Related]
5. Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas. Mimura T; Masuda A; Matsumoto I; Shiomi H; Yoshida S; Sugimoto M; Sanuki T; Yoshida M; Fujita T; Kutsumi H; Ku Y; Azuma T J Clin Gastroenterol; 2010 Oct; 44(9):e224-9. PubMed ID: 20453661 [TBL] [Abstract][Full Text] [Related]
6. A population-based, descriptive analysis of malignant intraductal papillary mucinous neoplasms of the pancreas. Le H; Ziogas A; Rhee JM; Lee JG; Lipkin SM; Zell JA Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2737-41. PubMed ID: 18843017 [TBL] [Abstract][Full Text] [Related]
7. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors. Hirono S; Tani M; Kawai M; Ina S; Nishioka R; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648 [TBL] [Abstract][Full Text] [Related]
8. Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms. Yoon WJ; Ryu JK; Lee JK; Woo SM; Lee SH; Park JK; Kim YT; Yoon YB Ann Surg Oncol; 2008 Nov; 15(11):3193-8. PubMed ID: 18784959 [TBL] [Abstract][Full Text] [Related]
9. Pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: could pancreaticogastrostomy be the anastomosis of choice? Gourgiotis S; Salemis NS; Kanakopoulos D; Germanos S JOP; 2010 Jul; 11(4):407-8. PubMed ID: 20601823 [No Abstract] [Full Text] [Related]
10. Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas. Fujii T; Kato K; Kodera Y; Kanda M; Nagai S; Yamada S; Kanzaki A; Sugimoto H; Nomoto S; Takeda S; Morita S; Nakamura S; Nakao A Surgery; 2010 Aug; 148(2):285-90. PubMed ID: 20434746 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology of intraductal papillary mucinous neoplasms of the pancreas: sex differences between 3 geographic regions. Ingkakul T; Warshaw AL; Fernández-Del Castillo C Pancreas; 2011 Jul; 40(5):779-80. PubMed ID: 21673537 [No Abstract] [Full Text] [Related]
16. High incidence of extrapancreatic neoplasms in patients with intraductal papillary mucinous neoplasms. Choi MG; Kim SW; Han SS; Jang JY; Park YH Arch Surg; 2006 Jan; 141(1):51-6; discussion 56. PubMed ID: 16415411 [TBL] [Abstract][Full Text] [Related]
17. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience. Yang AD; Melstrom LG; Bentrem DJ; Ujiki MB; Wayne JD; Strouch M; Bell RH; Rao SM; Talamonti MS Surgery; 2007 Oct; 142(4):529-34; discussion 534-7. PubMed ID: 17950345 [TBL] [Abstract][Full Text] [Related]
18. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma. Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881 [TBL] [Abstract][Full Text] [Related]
19. Clinical fate of branch duct and mixed forms of intraductal papillary mucinous neoplasia of the pancreas. Bournet B; Kirzin S; Carrère N; Portier G; Otal P; Selves J; Musso C; Suc B; Moreau J; Fourtanier G; Pradère B; Lazorthes F; Escourrou J; Buscail L J Gastroenterol Hepatol; 2009 Jul; 24(7):1211-7. PubMed ID: 19476563 [TBL] [Abstract][Full Text] [Related]
20. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Raut CP; Cleary KR; Staerkel GA; Abbruzzese JL; Wolff RA; Lee JH; Vauthey JN; Lee JE; Pisters PW; Evans DB Ann Surg Oncol; 2006 Apr; 13(4):582-94. PubMed ID: 16523362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]